Tau protein and beta amyloid in cerebrospinal fluid in patients with multiple sclerosis

被引：0
|
作者：
Talab, R [1 ]
Valis, M [1 ]
Andrys, C [1 ]
Talabova, M [1 ]
Krejsek, J [1 ]
机构：
[1] Fac Hosp, Hradec Kralove, Czech Republic
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2004年 / 154卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
626
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [21] Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis
    Augutis, Kristin
    Axelsson, Markus
    Portelius, Erik
    Brinkmalm, Gunnar
    Andreasson, Ulf
    Gustavsson, Mikael K.
    Malmestrom, Clas
    Lycke, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    Mattsson, Niklas
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 543 - 552
  • [22] Cerebrospinal fluid biomarkers of amyloid β-metabolism in multiple sclerosis
    Axelsson, M.
    Augutis, K.
    Portelius, E.
    Brinkmalm, G.
    Andreasson, U.
    Gustavsson, M.
    Malmestrom, C.
    Lycke, J.
    Blennow, K.
    Zetterberg, H.
    Mattsson, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 348 - 348
  • [23] Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature
    Frankfort, Suzanne V.
    Tulner, Linda R.
    van Campen, Jos P. C. M.
    Verbeek, Marcel M.
    Jansen, Rene W. M. M.
    Beijnen, Jos H.
    CURRENT CLINICAL PHARMACOLOGY, 2008, 3 (02): : 123 - 131
  • [24] Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too
    Kosehasanogullari, Gorkem
    Ozakbas, Serkan
    Idiman, Egemen
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2015, 136 : 107 - 109
  • [25] Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
    Jing Zhang
    Hayley A. Mattison
    Changqin Liu
    Carmen Ginghina
    Peggy Auinger
    Michael P. McDermott
    Tessandra Stewart
    Un Jung Kang
    Kevin C. Cain
    Min Shi
    Acta Neuropathologica, 2013, 126 : 671 - 682
  • [26] Amyloid-β peptide levels in serum and cerebrospinal fluid of multiple sclerosis patients
    Coyle, PK
    Mehta, PD
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 489 - 489
  • [27] Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
    Zhang, Jing
    Mattison, Hayley A.
    Liu, Changqin
    Ginghina, Carmen
    Auinger, Peggy
    McDermott, Michael P.
    Stewart, Tessandra
    Kang, Un Jung
    Cain, Kevin C.
    Shi, Min
    ACTA NEUROPATHOLOGICA, 2013, 126 (05) : 671 - 682
  • [28] Tau protein in cerebrospinal fluid and cognitive function in patients with a first clinical demyelinating event suggestive of multiple sclerosis
    Valis, M.
    Talab, R.
    Andrys, C.
    Krejsek, J.
    Masopust, J.
    JOURNAL OF NEUROLOGY, 2007, 254 : 101 - 102
  • [29] Cerebrospinal fluid tau and amyloid β42 protein in patients with myotonic dystrophy type 1
    Winblad, S.
    Mansson, J. E.
    Blennow, K.
    Jensen, C.
    Samuelsson, L.
    Lindberg, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (09) : 947 - 952
  • [30] Amyloid peptides and Tau proteins in cerebrospinal fluid of Parkinson patients
    Haegele, S
    Zerr, I
    Vogt, T
    MOVEMENT DISORDERS, 2004, 19 : S239 - S239
12345